Cristin-resultat-ID: 1943983
Sist endret: 25. januar 2022, 16:49
NVI-rapporteringsår: 2021
Vitenskapelig artikkel

Predicting diagnostic coding in hospitals: individual level effects of price incentives

  • Kjartan Sarheim Anthun


International Journal of Health Economics and Management
ISSN 2199-9023
e-ISSN 2199-9031
NVI-nivå 1

Om resultatet

Vitenskapelig artikkel
Publiseringsår: 2021
Publisert online: 2021
Sider: 1 - 18
Open Access


Scopus-ID: 2-s2.0-85116552817



Samfunnsmedisin, sosialmedisin • Helsetjeneste- og helseadministrasjonsforskning


Helseøkonomi • Helse- og sykehusadministrasjon • Finansiering av helsetjenester


  • Helsekategori: 20 - Generell helserelevans
    Aktivitet: 8.2 - Helse- og velferdsøkonomi

Beskrivelse Beskrivelse


Predicting diagnostic coding in hospitals: individual level effects of price incentives


The purpose of this paper is to test if implicit price incentives influence the diagnostic coding of hospital discharges. We estimate if the probability of being coded as a complicated patient was related to a specific price incentive. This paper tests empirically if upcoding can be linked to shifts in patient composition through proxy measures such as age composition, length of stay, readmission rates, mortality- and morbidity of patients. Data about inpatient episodes in Norway in all specialized hospitals in the years 1999–2012 were collected, N = 11  065  330. We examined incentives present in part of the hospital funding system. First, we analyse trends in the proxy measures of diagnostic upcoding: can hospital behavioural changes be seen over time with regards to age composition, readmission rates, length of stay, comorbidity and mortality? Secondly, we examine specific patient groups to see if variations in the price incentive are related to probability of being coded as complicated. In the first years (1999–2003) there was an observed increase in the share of episodes coded as complicated, while the level has become more stable in the years 2004–2012. The analysis showed some indications of upcoding. However, we found no evidence of widespread upcoding fuelled by implicit price incentive, as other issues such as patient characteristics seem to be more important than the price differences. This study adds to previous research by testing individual level predictions. The added value of such analysis is to have better case mix control. We observe the presence of price effects even at individual level.


Kjartan Sarheim Anthun

  • Tilknyttet:
    ved Helse ved SINTEF AS
  • Tilknyttet:
    ved Institutt for samfunnsmedisin og sykepleie ved Norges teknisk-naturvitenskapelige universitet
1 - 1 av 1